BCL2 and ovarian cancer: AM gene silencing decreased the expression of both AM mRNA and protein, blocked cell proliferation, and increased the chemosensitivity of HO8910 ovarian cancer cells via downregulation of Bcl-2/p-ERK expressions [250].